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Abstract
Lantibiotic synthetases are remarkable biocatalysts generating conformationally constrained peptides with a variety of
biological activities by repeatedly utilizing two simple posttranslational modification reactions: dehydration of Ser/Thr
residues and intramolecular addition of Cys thiols to the resulting dehydro amino acids. Since previously reported lantibiotic
synthetases show no apparent homology with any other known protein families, the molecular mechanisms and
evolutionary origin of these enzymes are unknown. In this study, we present a novel class of lanthionine synthetases,
termed LanL, that consist of three distinct catalytic domains and demonstrate in vitro enzyme activity of a family member
from Streptomyces venezuelae. Analysis of individually expressed and purified domains shows that LanL enzymes install
dehydroamino acids via phosphorylation of Ser/Thr residues by a protein kinase domain and subsequent elimination of the
phosphate by a phosphoSer/Thr lyase domain. The latter has sequence homology with the phosphothreonine lyases found
in various pathogenic bacteria that inactivate host mitogen activated protein kinases. A LanC-like cyclase domain then
catalyzes the addition of Cys residues to the dehydro amino acids to form the characteristic thioether rings. We propose that
LanL enzymes have evolved from stand-alone protein Ser/Thr kinases, phosphoSer/Thr lyases, and enzymes catalyzing thiol
alkylation. We also demonstrate that the genes for all three pathways to lanthionine-containing peptides are widespread in
Nature. Given the remarkable efficiency of formation of lanthionine-containing polycyclic peptides and the latter’s high
degree of specificity for their cognate cellular targets, it is perhaps not surprising that (at least) three distinct families of
polypeptide sequences have evolved to access this structurally and functionally diverse class of compounds.
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Introduction
Macrocyclization is a common strategy to constrain the
conformational flexibility of natural peptides of both ribosomal
and nonribosomal origin [1], thereby conferring increased
proteolytic stability and improved affinity for their targets.
Lantibiotic synthetases are remarkable catalysts that achieve
macrocyclization by utilizing two simple posttranslational modi-
fication reactions, dehydration of Ser/Thr residues and subse-
quent intramolecular addition of Cys thiols to the dehydro amino
acids to generate thioether crosslinks called (methyl)lanthionines
[2]. The resulting polycyclic products have high affinity for their
various targets, which to date all consist of small molecules [3]. For
instance, nisin binds with high affinity to the bacterial cell wall
precursor lipid II [4], and cinnamycin specifically recognizes
phosphatidyl ethanolamine [5]. Nisin is the most studied
lantibiotic [6] and has been used commercially to combat food-
borne pathogens for 40 years in more than 80 countries without
widespread development of resistance. A remarkable feature of
lantibiotic biosynthesis is the extraordinary efficiency by which one
or two enzymes typically generate 3–5 rings from a linear
precursor peptide. How these exceptional catalysts carry out their
reactions with apparently high promiscuity and yet a high degree
of control and what their evolutionary origin is has not been clear
since they have no obvious homology with other protein families in
the databases. In this study, we report the discovery of a new class
of lanthionine synthetases that provides important new insights
into both their mechanisms of catalysis as well as their likely
evolutionary origin.
Lantibiotics have been categorized into two classes based on
their biosynthetic pathways [7]. For class I lantibiotics, LanB
dehydratases convert Ser and Thr present in precursor peptides to
dehydroalanine (Dha) and Z-dehydrobutyrine (Dhb), respectively.
Subsequent intramolecular Michael addition of Cys thiols to Dha/
Dhb catalyzed by LanC cyclases form the characteristic
lanthionine (Lan, from Ser) and methyllanthionine (MeLan, from
PLoS Biology | www.plosbiology.org 1 March 2010 | Volume 8 | Issue 3 | e1000339Thr) thioether crosslinks (Figure 1A). Class II lantibiotics are
produced by bi-functional LanM modifying enzymes, which are
responsible for both dehydration and cyclization [8]. The C-
terminal cyclase domain of LanM proteins has sequence homology
with the LanC enzymes, but the N-terminal dehydratase domain
of LanM proteins has no homology with LanB enzymes [9].
Recent X-ray structure analysis and mutagenesis studies of LanC
enzymes and LanC-like domains in LanM proteins have provided
structural and mechanistic insights into the cyclization steps in
lantibiotic biosynthesis [10–13]. In contrast, the molecular
mechanism of the dehydration reaction by lantibiotic synthetases
remains an open question. In this paper, we conducted a search of
genome databases for putative alternative lantibiotic synthetases
and report the discovery of a new biosynthetic route to lantibiotic-
like peptides. We demonstrate in vitro activity for one member
from a cryptic gene cluster in the differentiating mycelial soil
bacterium Streptomyces venezuelae. This new class of enzymes
provides a rare glimpse into an evolutionary path leading to
lanthionine-containing peptides. Moreover, we show that the
genes for all three pathways to lanthionine-containing peptides are
widespread in nature and that they are not restricted to Gram-
positive bacteria as long believed.
Results
A Putative Lantibiotic Gene Cluster in Streptomyces
venezuelae
Analysis of the draft genome sequence of S. venezuelae revealed a
lantibiotic-like gene cluster (Figure 1B) with a gene encoding a
putative and unusual bifunctional lantibiotic synthetase with an N-
terminal region (residues 225–480) resembling a serine/threonine
kinase instead of the dehydratase domain found in LanM
enzymes. At its C-terminus, the protein contains a LanC-like
cyclization domain (residues 540–930) (Figure 1C). A nearby small
open reading frame has all the hallmarks of a putative lantibiotic
precursor gene including a series of Cys, Ser, and Thr residues that
are localized in the C-terminal part of the gene product
(Figure 1D).
A search of the publicly available databases uncovered at least
nine other gene clusters that encode proteins with an N-terminal
serine/threonine kinase-like domain and a C-terminal LanC-like
domain (Table S1). We hypothesized that these proteins would be
novel bifunctional lanthionine synthetases in which the N-terminal
region containing the kinase-like domain and the C-terminal
LanC-like domain would be responsible for dehydration and
cyclization, respectively. Continuing the common nomenclature
for lantibiotic biosynthetic genes, we refer to them as LanL
proteins with the enzyme from S. venezuelae given the annotation
VenL and its putative substrate VenA. Located immediately
downstream of venL and venA (Figure 1B) are two genes, venT and
venH, that appear to encode the ATP-binding and membrane
permease subunits, respectively, of an ABC transporter that may
be involved in export of the modified peptide out of the cell as
occurs for many lantibiotics.
Interestingly, the ven cluster does not contain apparent
immunity genes unless that role is fulfilled entirely by the putative
transport genes venTH, which is not common for lantibiotics.
Consistent with other sequenced lantibiotic gene clusters of
actinomycete origin [14,15], no genes are present encoding a
protease or protease domain that might be involved in cleavage of
the leader peptide. Nor does the cluster contain any regulatory
genes, although the latter is not unprecedented in actinomycete
antibiotic gene clusters (e.g., the erythromycin biosynthetic gene
cluster of Saccharopolyspora erythraea) [16].
VenL Dehydrates and Cyclizes VenA
To verify the hypothesized function, venL and venA were cloned
and heterologously expressed in Escherichia coli. VenA was
produced as a fusion protein with an N-terminally located
maltose-binding protein (MBP) and hexahistidine tag (His6)t o
improve its solubility and provide ease of purification, respectively.
The fusion protein was purified by immobilized metal affinity
Figure 1. Putative lantibiotic biosynthesis in S. venezuelae. (A)
Posttranslational modification of precursor peptides by lantibiotic
synthetases. Following ribosomal synthesis of the precursor peptides,
LanB or LanM enzymes dehydrate Ser and Thr to afford Dha and Dhb,
respectively. Subsequently, LanC or LanM catalyze intramolecular
addition of Cys thiols onto the dehydro amino acids in a stereo- and
regio-selective manner to form Lan and MeLan. (B) The biosynthetic
gene cluster of S. venezuelae consists of the synthetase gene venL, the
precursor gene venA, and two components of an ABC transporter venT
and venH, encoding the ATP-binding and permease subunits,
respectively. (C) A conserved domain search for VenL identified a
putative protein kinase domain and LanC-like domain shown in blue
and red, respectively. Location of conserved residues in the domains is
shown as colored boxes. (D) Primary sequence of VenA. The cysteine
residues and possible dehydration sites are highlighted in red and blue,
respectively. The putative core region is underlined.
doi:10.1371/journal.pbio.1000339.g001
Author Summary
Many bacteria generate cyclic peptides, which have
improved biological activities compared to linear peptides,
including higher stability. Lanthionine-containing peptides
are one such group, and different members of this group
have antibiotic, anti-inflammatory, and anti-viral activities.
For example, one lanthionine-containing peptide called
nisin has been used to protect food items from harmful
bacteria. Two different pathways for the biosynthesis of
lanthionine-containing peptides have been described
previously. By comparing the DNA sequences of bacterial
genomes we reveal a third biosynthetic route that
provides further insight into how the biosynthetic
pathways for these cyclic peptides have evolved. We
characterized the novel lanthionine synthetase utilized in
this third pathway in the soil bacterium Streptomyces
venezuelae and show that the purified enzyme catalyzes
the chemical reactions necessary to turn a linear peptide
into a peptide with multiple rings. The discovery of this
third biosynthetic pathway widens the scope for the
engineering of new lanthionine-containing peptides for
potential use in human therapeutics.
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etch virus protease to obtain His6-VenA with a predicted mass of
7,552.5 (Figure 2A). VenL was also produced with an N-terminal
His6-tag (His6-VenL) and purified by IMAC and gel filtration
chromatography (Figure S1). His6-VenA was incubated with His6-
VenL in the presence of adenosine triphosphate (ATP), MgCl2,
and tris(2-carboxyethyl)phosphine (TCEP) and after 3 h subjected
to matrix-assisted laser desorption/ionization time-of-flight mass
spectrometry (MALDI-ToF MS). After incubation with His6-
VenL, His6-VenA was converted into a product with a mass
corresponding to the loss of four molecules of water (272 Da)
(Figure 2B). This result clearly demonstrated that His6-VenL
carried out the dehydration of all four Ser/Thr residues present in
the putative core peptide of VenA, the region of the precursor
peptide that undergoes the posttranslational modifications (under-
lined sequence, Figure 1C) [17]. The molecular weight of a
cyclized or uncyclized product is identical, and therefore we
determined the presence of any free Cys thiols in VenA after VenL
treatment by reaction with iodoacetamide (IAA), a well-known
thiol-selective alkylation agent. As expected, when intact His6-
VenA was treated with IAA, its mass increased by 228 Da,
corresponding to alkylation of the four Cys in the core peptide
(Figure S2B). In contrast, IAA treatment of His6-VenA after
incubation with His6-VenL did not result in detectable alkylation
products, indicating that the great majority of free thiols were
converted to thioether rings (Figure S2C). Taken together, these
results demonstrate that VenL functions as a bifunctional enzyme
that catalyzes both dehydration and cyclization reactions.
The N-Terminal Region of VenL Is Responsible for
Dehydration of VenA
To address the hypothesis that the N-terminal region of VenL
containing the kinase-like domain would be involved in dehydra-
tion of the Ser/Thr residues in VenA, a gene encoding a truncated
protein lacking the C-terminal cyclase domain of VenL (VenL-
DC) was constructed. VenL-DC was expressed and purified with
an N-terminal His6-tag and shown to catalyze the 4-fold
dehydration of His6-VenA (Figure 2C). IAA treatment resulted
in four alkylations (Figure S2D) and no detectable cyclized product
lacking any of the alkylations, showing that the N-terminal region
of VenL is responsible for the dehydration activity of VenL but has
no or greatly reduced cyclase activity. Moreover, these findings
strongly suggest that non-enzymatic cyclization is not responsible
for the lack of free thiols after incubation of His6-VenA with
full length VenL. VenL-DC is the first example of an in vitro
reconstituted active, monofunctional peptide dehydratase.
Sequence Alignment of LanL Enzymes with Protein
Kinases and OspF Family Members
To provide insights into the mechanism whereby VenL
dehydrates rather than phosphorylates Ser and Thr residues, the
N-terminal region of LanL proteins was aligned with RamC
protein family members and known protein kinases. RamC is
involved in the biosynthesis of SapB [18], a lantibiotic-like
morphogenetic peptide that plays a role in sporulation in
streptomycetes. RamC possesses an N-terminal kinase-like domain
similar to LanL [19] but lacks a prototypical C-terminal cyclase-
like domain with its characteristic zinc binding site and active site
residues [2,11,12]. Figure 3A shows the result of sequence
alignment analysis of the N-terminal regions of five LanL proteins
with two RamC family proteins and three bona fide protein kinases.
The alignment clearly indicates that the C-terminal part of the
analyzed region of LanL (residues 230–487 in VenL) contains
conserved kinase-like sequence motifs (blue stars, Figure 3A). On
the other hand, its N-terminal part (residues 1–229 in VenL)
showed no sequence homology to kinases, whereas it shares some
homology with members of the RamC protein family. Based on
this result, we postulated that the N-terminal part of LanL might
be important for the b-elimination reaction of the phosphate
group of phosphoserine/threonine to afford Dha and Dhb
residues.
To test this model, additional sequence alignments were carried
out of the N-terminal part of LanL and RamC with the OspF
protein family (Figure 3B). Members of this family are phospho-
threonine lyase effector proteins that catalyze the irreversible b-
elimination reaction of a phosphate group from a phosphothreo-
Figure 2. MALDI-ToF MS analysis of in vitro enzyme assays of
His6-VenA with VenL and VenL deletion proteins. Mass spectra
are depicted of (A) His6-VenA, (B) His6-VenA after incubation with His6-
VenL, (C) His6-VenA after incubation with His6-VenL-DC, (D) His6-VenA
after incubation with His6-VenL-DLC, and (E) His6-VenA after incubation
with both His6-VenL-DLC and His6-VenL-DKC. The assignments of
observed peaks are shown in the spectra, in which SM indicates the
starting material (His6-VenA).
doi:10.1371/journal.pbio.1000339.g002
A New Class of Lanthionine Synthetases
PLoS Biology | www.plosbiology.org 3 March 2010 | Volume 8 | Issue 3 | e1000339nine to produce a Dhb residue in their substrate proteins, mitogen-
activated protein kinases (MAPKs) [20–23]. Several pathogenic
bacteria use this strategy to modulate host signaling pathways. The
alignment revealed that the N-terminal region of VenL possesses
conserved motifs characteristic of the OspF family. In particular,
four of six residues proposed as catalytic site residues in
phosphothreonine lyases based on a crystal structure [21,22] are
conserved in LanL enzymes (red stars, Figure 3B). Taken together,
the sequence alignment analysis suggests that LanL enzymes
consist of three catalytic domains: a phosphoserine/threonine
Figure 3. Sequence alignment of LanL protein family members with other proteins. (A) Alignment of the N-terminal regions of the LanL
family with RamC, AmfT and three protein kinases (PK-1 from S. clavuligerus ATCC 27064, YP_002190269; PksC from Streptomyces coelicolor A3(2),
NP_628010; and PKA from mouse, NP_032880). Fully and partially conserved residues are highlighted in yellow and green, respectively, with cyan
indicating similar amino acids. Roman numerals refer to subdomains conserved across the Ser/Thr protein kinase family. Blue stars indicate the amino
acids that are highly conserved in protein kinases. (B) The N-terminal regions of the LanL family, which exhibit no homology with kinases, were
aligned with RamC family (RamC and AmfT) and OspF family (OspF, SpvC, and HopAI1) members. Color coding as in (A). Red stars indicate catalytic
residues in the proposed mechanism of SpvC that are conserved in the LanL family, and black stars indicate proposed catalytic residues that are not
found in LanL proteins. For full sequences and accession codes, see Figures S6 and S8.
doi:10.1371/journal.pbio.1000339.g003
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domain that act together to form Lan and MeLan.
Catalytic Activity of VenL-DLC and VenL-DKC
To verify the hypothesis that LanL enzymes consist of three
catalytic modules, we constructed two His6-tagged VenL trunca-
tion mutants consisting of only the kinase domain (residues 201–
513, VenL-DLC) or only the putative phosphoserine/threonine
lyase domain (residues 1–212, VenL-DKC). Incubation of His6-
VenA with His6-VenL-DLC gave a series of new peaks in the mass
spectrum corresponding to two, three, and four phosphorylations
of VenA (Figure 2D), demonstrating the kinase activity of VenL-
DLC. When His6-VenA was incubated in the presence of both
His6-VenL-DLC and His6-VenL-DKC, dehydration of VenA was
observed albeit with incomplete conversion (Figure 2E), showing
that VenL-DKC can catalyze the b-elimination of phosphate
groups present in phosphorylated VenA to afford Dha/Dhb
residues. Collectively, these results are consistent with dehydratase
activity of VenL being divided into two distinct catalytic modules,
a central kinase domain and an N-terminal lyase domain.
Investigation of the ven Gene Cluster
To determine the possible physiological function of VenA, both
venA and venL were deleted individually from the S. venezuelae
genome. Neither deletion had an effect on cell growth or
morphological differentiation, and no difference was observed
between the mutants and the wild type strain when screened
against Micrococcus luteus ATCC4698 for antibiotic activity on 10
different solid growth media. An attempt to enhance expression of
the ven gene cluster by introducing the strong constitutive ermE*
promoter upstream of venL in S. venezuelae did not yield any
phenotypic differences using the same screening conditions.
MALDI-ToF analyses of culture supernatants of the wild type
and mutant strains grown in different liquid media gave identical
spectra, and the wild type culture failed to reveal a peptide
corresponding in mass to the in vitro produced compound or to
any analogs differing in the site of leader peptide cleavage, number
of dehydrations, or that had retained the leader peptide.
Apparently the ven gene cluster is not expressed in its natural host
under the growth conditions used.
Consequently, cosmids containing the wild type ven gene cluster,
as well as the venL- and venA-deleted versions, were introduced into
Streptomyces lividans by conjugation in an attempt to obtain
heterologous expression. No phenotypic differences were observed
between the three ex-conjugants, and MALDI-ToF analyses of
culture supernatants again failed to identify a peptide with any
predicted masses. It is conceivable that some unknown environ-
mental signal is required to activate ven gene expression. The
absence of genes with putative regulatory and proteolytic functions
and potentially self-resistance mechanisms, and the possibility that
they lie elsewhere in the genome of S. venezuelae, might also explain
the failure to detect heterologous expression of the ven gene cluster
in S. lividans.
Determination of the Ring Topology of VenL-Processed
VenA
With few exceptions [24,25], all lantibiotics known to date were
first isolated and purified from natural sources. On the other hand,
these investigations into VenA originated from a bioinformatic
approach, and to date we have not succeeded in detecting
production of the peptide by S. venezuelae or after cloning the gene
cluster in S. lividans, which is often used to express heterologous
gene clusters of actinomycete origin. Therefore, the structure of
the mature peptide, which we have termed venezuelin, is
unknown. To gain insight into the topology of the lanthionine
rings in VenA after processing by VenL, a series of VenA analogs
were made in which each cysteine residue was replaced with an
alanine residue (VenA-C32A, VenA-C34A, VenA-C45A, and
VenA-C50A). Ala29 in the leader peptide region was also replaced
with a Lys in these VenA analogs to improve their solubility. Each
VenA analog was incubated with His6-VenL followed by
endoproteinase Glu-C treatment to yield the C-terminal cyclized
peptide spanning Thr18-Ala51, and subsequently subjected to
electron spray ionization-quadrupole/ToF (ESI-Q/ToF) MS
(Figure S3).
In the tandem mass spectra of the VenA, VenA-C34A, and
VenA-C45A peptides, no fragmentation was observed in the C-
terminal region (Dhb31–Ala51) except for a fragment ion resulting
from cleavage between Cys50 and Ala51 (Figure 4A–C). This
observation suggests that the processed VenA peptide contains
overlapping cyclic structures between Dhb31 and Cys50; such
cyclic structures are less susceptible to fragmentation than linear
regions [8]. Additional ions were observed in the C-terminal
region in the spectrum of VenL-processed VenA-C32A
(Figure 4D), providing more insights into the ring pattern. Two
segments were still protected from fragmentation (Cys34–Dhb39
and Cys45–Dha49), implying the formation of a MeLan between
Cys34 and Dhb39 and a Lan between Cys45 and Dha49. The
fragmentations that are observed around Dhb32 and Dhb43 in
Figure 4. Determination of the structure of venezuelin. Red
arrows indicate the b and y0 ions observed in ESI tandem mass spectra
of the products of incubation with His6-VenL followed by treatment
with GluC. The observed fragmentation pattern is shown for (A) VenL-
modified VenA, (B) VenL-modified VenA-C34A, (C) VenL-modified VenA-
C45A, (D) VenL-modified VenA-C32A, and (E) VenL-modified VenA-
C50A. Dehydrated amino acids and cysteine residues in each analog are
shown in blue and green, respectively. See Figure S3 for the MS/MS
spectra. (F) The topology of (methyl)lanthionines in venezuelin.
Magenta arrows indicate the position and direction of Lan/MeLan ring
formation.
doi:10.1371/journal.pbio.1000339.g004
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partners would be Cys32 and Cys50, are not cyclized. Hence,
disruption of a MeLan involving Cys32, which is mutated in
VenA-C32A, appears to interfere with formation of another ring.
Nonetheless, the fragmentation pattern limits the ring topology to
two possibilities: Cys32–Dhb43 and Cys50–Dhb31, or Cys32–
Dhb31 and Cys50–Dhb43, in addition to the two assigned rings
(Cys34–Dhb39 and Cys45–Dha49). VenA-C50A was also treated
with VenL and the product analyzed by ESI-Q/ToF MS
(Figure 4E). The large number of fragmentations in the C-
terminal region suggests that Cys45 is not cyclized by VenL when
Cys50 is mutated. On the other hand, protection from
fragmentation in the N-terminal region strongly supports ring
formation between Cys32 and Dhb43. With three rings assigned,
the final ring would have to form between Cys50 and Dhb31.
Collectively, the only structure that can account for the regions
that are protected from fragmentation in all VenA peptides tested
is the ring topology shown in Figure 4F. Future NMR studies will
be needed to further confirm this structure, but these will require
much larger amounts of material than can currently be obtained.
The proposed ring pattern is not found in known lantibiotics
and most closely resembles the globular structures of cinnamycin
and the duramycins, also products of streptomycetes [14,26]. Both
cinnamycin/duramycin and the structure proposed here for
venezuelin contain four overlapping rings with one particularly
large ring structure encompassing 18 amino acids in cinnamycin/
duramycin and 20 amino acids in venezuelin.
In Vitro Production of Venezuelin
Given the difficulties encountered in detecting venezuelin
production in both S. venezuelae and S. lividans, we sought to apply
in vitro techniques. All lantibiotics characterized thus far require
the removal of the N-terminal leader sequence of the modified
precursor peptide to attain their active forms. Since the cluster
does not contain an identifiable protease or protease domain that
might provide insights, the site of protease cleavage is unknown.
However, a peptide with sequence homology to VenA encoded in
the genome of Streptomyces clavuligerus has an AlaPheAla sequence
that is identical to the cleavage site found in the CinA precursor to
the lantibiotic cinnamycin (Figure S4A). For cinnamycin, this
cleavage site is thought to be recognized by a protease of the
secretory machinery [14]. In VenA, this AlaPheAla-like sequence
is a ProPheAla sequence spanning positions 27–29. Thus, several
mutant VenA peptides were generated in which cleavage sites for
commercial proteases were engineered such that after proteolysis
the C-terminal product would be that predicted by a ProPheAla
cleavage site (Figure S5A). Alternatively, GlyAla and AlaAla
sequences are found in VenA that could be potential cleavage sites
for a protease of the double-Gly type that are found in class II
lantibiotics [27]. These sequences are located at positions 25–26
and 29–30 of VenA, respectively. To investigate these potential
cleavage sites, a series of VenA analogues were generated in which
either a Lys-C/trypsin or Factor Xa cleavage site was introduced
(Figure S5A). All five mutant peptides were expressed and purified
as His6-tagged peptides and incubated with His6-VenL resulting in
the anticipated four dehydrations. Furthermore the products were
devoid of free thiols as determined by IAA alkylation as described
above. All VenL-processed peptides were then treated with the
corresponding protease and the products were tested against
Micrococcus luteus ATCC4698, Lactococcus lactis HP, and Bacillus
subtilis LH45 using well-diffusion assays. These three strains are
highly susceptible to a wide range of lantibiotics. However, no
antimicrobial activity was detected (Figure S5B) under the
conditions used.
Discussion
We describe a novel class of lanthionine synthetases
consisting of three catalytic modules (Figure 5A) that install
the thioether rings via phosphorylation of Ser/Thr residues by
a kinase-like domain, elimination of the phosphate by a lyase
domain, and cyclization by a LanC-like cyclase domain
(Figure 5B). These enzymes appear to possess the same
cyclization strategy as the previously discovered LanM and
LanC proteins, retaining the conserved zinc binding site that is
believed to activate the Cys residues for nucleophilic attack
onto the dehydro amino acids [10–12]. However, the
dehydration reaction is carried out in two separate domains
that have no significant sequence homology with either the
LanB or the LanM proteins (Figures S7, S8, and S9). The
central part of LanL proteins (residues 230–487 in VenL)
contains all 12 conserved subdomains of protein serine/
threonine kinases [28]. Importantly, the highly conserved
residues in these kinases are also well conserved in LanL
proteins. On the other hand, the characteristic kinase motifs
found in VenL are not conserved in either LanB or LanM
enzymes (Figures S8 and S9B).
The N-terminal part (residues 1–163) of VenL has homology to
members of the OspF protein family. Most importantly, Lys51,
His53, Arg83, and Tyr108 in VenL align well with the residues
that play essential roles in catalysis by OspF enzymes (Lys104,
His106, Lys136, and Tyr158 in SpvC, an OspF family member
from Salmonella). In the proposed catalytic mechanism of SpvC
based on an X-ray structure [21], Lys104 and Tyr158 donate
hydrogen bonds to the carbonyl oxygen of the target phospho-
threonine to decrease the pKa of its a proton. Lys136 is the
catalytic base that abstracts the a proton triggering the b-
elimination of phosphate, with His106 protonating the oxygen of
the phosphate leaving group. An important difference between the
OspF and LanL proteins is that the latter process several
phosphorylated Ser/Thr residues present in one peptide, unlike
the OspF family, which recognizes one specific phosphoThr in
host MAPKs. The essential residues of the lyase domain are not
found in LanB proteins (Figure S9), but sequence alignments with
a series of LanM enzymes suggested that possibly some of the
Figure 5. Posttranslational modification by LanL enzymes. (A)
Illustration of the three catalytic domains constituting LanL enzymes. The
positions of conserved residues important for catalysis are shown in darker
colors. (B) Scheme of post-translational modification by LanL enzymes to
install Lan/MeLan into the substrate LanA peptides. R=H or Me.
doi:10.1371/journal.pbio.1000339.g005
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of LanM enzymes (Figure S7A). To test the functional importance
of these residues, mutants were generated in a representative
LanM enzyme (lacticin 481 synthetase; LctM) in which the
conserved residues that may be part of a putative lyase active site
were mutated (Lys227Met, Tyr225Ala, and the double mutation
Arg226Met/Lys227Met). When incubated with the LctA sub-
strate, all three mutants had full dehydration activity (Figure S7B),
strongly suggesting that these residues are not part of a lyase
domain in LctM.
The discovery of a third route for the synthesis of lanthionine-
containing peptides illustrates the biological importance of these
conformationally constrained peptides. Given the remarkable
efficiency of forming polycyclic peptides from linear ribosomally
produced peptides and their proven capability to recognize
molecular targets with high affinities, it is perhaps not surprising
that nature has evolved three distinct families of polypeptide
sequences in order to access the reactive dehydro amino acids
Dha and Dhb. A search of the available protein databases shows
that the genes responsible for the three strategies for lanthionine
biosynthesis are widespread, with some species containing two
or all three pathways; e.g., LanL and LanB in Streptomyces
clavuligerus and Streptomyces griseus, LanM and LanB in Streptococcus
pyogenes and Lactococcus lactis, and all three pathways in
Streptococcus pneumoniae ( F i g u r e6 ) .T h ew e a l t ho fg e n o m i c
information that is now available shows that putative lantibiotic
biosynthetic gene clusters are not restricted to Gram-positive
organisms as long believed (see also [29]). Such gene clusters are
also found in Gram-negative bacteria such as the proteobacter-
ium Myxococcus xanthus and in cyanobacteria such as Nostoc
punctiforme.
We propose that the VenL proteins evolved from stand alone
protein Ser/Thr kinases and phosphoSer/Thr lyases. The OspF
proteins likely evolved high substrate specificity from a promiscu-
ous ancestor, whereas the LanL proteins maintained low substrate
specificity. Interestingly, although LanM enzymes do not contain
the characteristic motifs of Ser/Thr kinases or phosphoThr lyases
(Figures S7 and S8), recent in vitro studies of a LanM
demonstrated that the Ser/Thr residues in the precursor peptide
are phosphorylated followed by phosphate elimination to generate
the dehydro amino acids [30,31]. Thus, while on the sequence
level the dehydratases in the three classes of peptide dehydratases
have no obvious homology, the chemical logic to carry out the
dehydration reaction may well be similar.
Interestingly, all three classes of putative lantibiotic synthetases
utilize the same cyclization strategy. As mentioned previously [3],
the cyclization reaction is chemically not very demanding and
takes place readily non-enzymatically. However, control over
chemo- and regio-selectivity requires enzyme catalysis [32],
suggesting that primordial lantibiotics may have been mixtures
of non-enzymatically cyclized compounds that became enzyme-
guided to enrich the biologically active isomers by acquisition of
zinc-containing proteins that are used widespread in nature for
thiol alkylation [33,34].
Historically, lantibiotics have been discovered from antimi-
crobial screens, but as more and more genomes are sequenced,
bioinformatic analyses are likely to become a major route to the
discovery of new compounds and one that is not limited by the
biological activity defined by the screen. Many of the
lantibiotic-like gene clusters discovered by genome scanning
may direct the production of peptides that do not have
antibiotic activity, but that may act, for example, as signaling
molecules. In fact, two lanthionine-containing peptides from
streptomycetes with morphogenetic activities have already been
reported [18,35]. Moreover, given the extraordinary efficiency
of producing conformationally constrained peptides by the
dehydration/cyclization strategy, it is likely that compounds
generated by genetic diversification will have a variety of
biological activities. The name lantibiotics was introduced in
1988 as a shortcut for lanthionine-containing antibiotics [36].
We would like to suggest the name lantipeptides for compounds
that by structure and biosynthetic strategy are clearly related to
lantibiotics but that are not known to possess antimicrobial
activity.
In summary, a new family of lanthionine synthetases termed
LanL was discovered in S. venezuelae that contain a phosphoSer/
Thr lyase domain, a kinase domain, and a cyclase domain.
These novel enzymes provide unique new insights into the
potential evolutionary origin and the mechanism of these
remarkable catalysts. The approach taken here demonstrates
that genome scanning, combined with in vitro enzymology, can
be a potential strategy to reveal novel mechanistic and
evolutionary insights. The genes encoding LanL proteins are
widespread in nature, as are lantibiotic/lantipeptide biosynthetic
gene clusters in general.
Materials and Methods
Materials
S. venezuelae ATCC10712 was maintained as previously
described [37]. Methods for cloning and protein purification are
provided in the Supporting Information (Text S1 and Table S2).
Modification Assay of His6-VenA with His6-VenL
Analogues
His6-VenA was incubated with His6-VenL, His6-VenL-DC,
His6-VenL-DLC, or both His6-VenL-DLC and His6-VenL-DKC
(final concentration: 2 mM each for His6-VenL and His6-VenL-
DC, 4 mM each for His6-VenL-DLC and His6-VenL-DKC) in a
reaction buffer that contained (final concentrations) 50 mM
HEPES?Na buffer (pH 7.5), 10 mM MgCl2, 2.5 mM ATP,
1 mM TCEP, 25 mM His6-VenA, and 5% DMSO. The reactions
with His6-VenL and His6-VenL-DC were incubated at 25uC for
3 h and the assays with His6-VenL-DLC or His6-VenL-DKC were
incubated for 15 h. For mass spectrometric analysis, 10 mL of each
reaction mixture was desalted using ZipTipC18 (Millipore), eluted
with 1 mL of a 75% MeCN/25% water solution containing 0.1%
TFA and saturated sinapinic acid, and spotted onto the target
plate for analysis by using a Voyager-DE-STR mass spectrometer
(Applied Biosystems).
IAA Modification Assay of Modified His6-VenA
After incubation of His6-VenA with His6-VenL in 20 mLo f
modification assay buffer, 6 mL of IAA reaction buffer (330 mM
Tris-HCl buffer pH 8.5, 33 mM IAA, 6.7 mM TCEP) was added.
The solution was incubated at 25uC for 15 h, desalted using
ZipTipC18, and subjected to MALDI-ToF MS.
LC-ESI-Q/ToF MS Analysis of Cyclized VenA Analogs
After treatment of each His6-VenA analog with His6-VenL,
0.3 U of endoproteinase Glu-C (Fluka) was added to 20 mLo f
assay solution. The solution was further incubated at 25uC for
18 h. An aliquot of 10 mL of the resulting sample was fractionated
on an Acquity UPLC (Waters) equipped with a C8 column
(100 mm61 mm) using a gradient of 3%–97% B over 12 min
(A= water containing 0.1% formic acid, B= methanol containing
0.1% formic acid), and directly subjected to ESI-Q/ToF MS
(Synapt MS system, Waters). Nitrogen was used as cone gas
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voltage was set to 3.5 kV. The ionization source and desolvation
gas were heated to 120uC and 300uC, respectively. The ions
having m/z=1,104.34 (trivalent ion of VenA) or 1,093.65
(trivalent ions for the VenA mutants) were fragmented with a
trap collision energy of 20–40 V. The acquired spectrum was
converted to a deconvoluted spectrum by using the MaxEnt3
program (Waters).
Supporting Information
Figure S1 SDS-PAGE analysis of the proteins used in
this study. Lane 1, BioRad low range molecular weight
standards. Lane 2, VenL full length protein (Calculated M.W.:
103 kDa); lane 3, VenL-DC (VenL truncated protein, 1–513 aa,
Calculated M.W.: 57 kDa); lane 4, VenL-DKC (1–212 aa,
Calculated M.W.: 25 kDa); lane 5, VenL-DLC (kinase domain,
Figure 6. Phylogenetic tree of 16S rRNA of species having putative lantibiotic synthetase genes. Species with lanL, lanB, and lanM genes
are highlighted in yellow, green, and magenta, respectively. The phylogenetic tree was constructed based on the Ribosomal Database Project [38].
For the bacterial strains used and gene accession numbers, see Tables S3 and S4.
doi:10.1371/journal.pbio.1000339.g006
A New Class of Lanthionine Synthetases
PLoS Biology | www.plosbiology.org 8 March 2010 | Volume 8 | Issue 3 | e1000339201–513 aa, Calculated M.W.: 35 kDa); lane 6, Bio-Rad
prestained SDS-PAGE standards, broad range.
Found at: doi:10.1371/journal.pbio.1000339.s001 (0.43 MB
TIF)
Figure S2 MALDI-ToF MS analysis of IAA modification
assay of His6-VenA. Mass spectra of (A) His6-VenA without
IAA treatment, (B) His6-VenA after IAA treatment, (C) His6-VenA
after incubation with His6-VenL followed by IAA treatment, and
(D) His6-VenA after incubation with His6-VenL-DC followed by
IAA treatment are shown.
Found at: doi:10.1371/journal.pbio.1000339.s002 (0.22 MB TIF)
Figure S3 Tandem mass spectra of VenA analogs
modified by VenL. ESI-Q/ToF MS spectra of (A) VenA, (B)
VenA-C32A, (C) VenA-C34A, (D) VenA-C45A, and (E) VenA-
C50A after VenL treatment followed by Glu-C cleavage are
shown. b and y0 ions are marked in the spectra. ‘‘i(XXXXX)’’
labels indicate the ions corresponding to internal peptide
fragments resulting from two fragmentations. Asterisks indicate
the peaks originating from the non-fragmented parent peptide,
such as [M+H]
+ and [M+2H]
2+.
Found at: doi:10.1371/journal.pbio.1000339.s003 (1.37 MB TIF)
Figure S4 Sequence alignments of VenA and its homo-
logue, SclA. All lantibiotics known to date require the removal of
the N-terminal leader sequence of the modified precursor peptide
to attain their active forms. Since venezuelin production by S.
venezuelae has not yet been detected and since the cluster does not
contain a protease that might provide insights, the site of protease
cleavage is unknown. However, a peptide with sequence homology
to VenA encoded in the genome of Streptomyces clavuligerus has an
AFA sequence (panel A). Identical and similar residues are
highlighted in yellow and cyan, respectively. The same AFA
sequence motif has been predicted to be the recognition site for
removal of the leader peptide of cinnamycin by Type I signal
peptidases of the general secretory pathway [14]. In VenA, the
homologous sequence is PFA
29–A
30, and we infer that the VenL-
modified VenA is likely cleaved between Ala29 and Ala30 upon
secretion (thick arrow). Taken together with the results of tandem
mass spectrometry of the VenA derivatives, we propose the
structure of venezuelin shown in Figure S4B. Thin arrows indicate
the proposed Lan/MeLan ring formation in venezuelin. Attempts
to detect production of the lanthionine-containing peptide of
Streptomyces clavuligerus were unsuccessful.
Found at: doi:10.1371/journal.pbio.1000339.s004 (0.44 MB TIF)
Figure S5 Bioactivity assay of venezuelin analogs pre-
pared in vitro. (A) Sequences of VenA mutants constructed to
engineer protease recognition sites (shown in red, K for trypsin/
LysC cleavage; IEGR for Factor Xa/trypsin cleavage) at various
potential leader peptide cleavage sites. (B) Antimicrobial activity
assay of the VenA mutants processed by VenL and subsequently
treated with protease. The products were tested against B. subtilis
LH45, M. luteus ATCC4698, and L. lactis HP. Spot 1, DMSO
(negative control); spot 2, VenL and trypsin (negative control);
spots 3–8, various amounts of VenA mutants modified by VenL
and treated with trypsin; spot 9, haloduracin (positive control).
None of the venezuelin analogs showed antimicrobial activity
under these conditions. The very faint zones seen in all cases (but
most obviously for L. lactis HP) are attributed to DMSO (negative
control in spot 1), which was required because of the very poor
aqueous solubility of VenA and its processed derivatives.
Found at: doi:10.1371/journal.pbio.1000339.s005 (1.71 MB TIF)
Figure S6 Sequence alignments of LanL family mem-
bers. For more information on the LanL sequences, see Table S1.
For more information on the strains used to generate the figure,
see Tables S2 and S3.
Found at: doi:10.1371/journal.pbio.1000339.s006 (7.54 MB TIF)
Figure S7 LanM enzymes do not contain the lyase
domain found in the LanL family. (A) Sequence alignment
between 10 LanL proteins and four selected LanM proteins. The
alignments suggest that the lyase domain found in LanL proteins is
not present in LanM proteins since the catalytic residues involved
in the lyase activity of the OspF family and conserved in the LanL
family (red stars) are not conserved in LanM. However, some weak
sequence similarity between the lyase domains of the LanL family
and LanM enzymes is shown around residue 149 of VenL (red
bar); no significant homology was observed in other regions. (B)
Substrate modification assays with VenL-DC, LctM, and LctM
mutants, in which the residues in the putative lyase domains of
LanLs and LanMs were mutated in lacticin 481 synthetase (LctM).
All mutants at these residues (Y225A, K227M, R226M/K227M)
showed dehydration activity with the LctA substrate peptide
similar to that of the wild-type LctM, which is shown for
comparison. These results demonstrate that the region with weak
homology does not play an important role in the dehydration
activity of LctM.
Found at: doi:10.1371/journal.pbio.1000339.s007 (2.95 MB TIF)
Figure S8 Sequence alignments of Ser/Thr protein
kinases and the N-termini of selected LanM proteins.
The conserved residues that provide the catalytic loop and ATP
binding pocket in the Ser/Thr kinases and LanL proteins are
highlighted in cyan and are not conserved in LanM proteins. The
few residues in LanM that do exhibit similarity to the conserved
residues in Ser/Thr kinases are highlighted in green.
Found at: doi:10.1371/journal.pbio.1000339.s008 (4.53 MB TIF)
Figure S9 Sequence alignment of LanB proteins with
LanL proteins and with Ser/Thr protein kinases. (A)
Alignment of the lyase domains of the LanL family with LanB
enzymes. The alignments suggest that the lyase domain is not
present in LanB proteins since the essential catalytic residues in
this domain, determined by studies on the OspF family of proteins
(red stars), are not conserved in LanB. (B) Sequence alignments
between protein kinases and LanB proteins. The conserved
residues that provide the catalytic loop and ATP binding pocket
in protein kinases are highlighted in cyan and are not conserved in
LanB proteins. The residues in LanB that exhibit similarity to the
conserved amino acids in the catalytic loop/ATP binding pocket
of protein kinases are highlighted in green.
Found at: doi:10.1371/journal.pbio.1000339.s009 (7.53 MB TIF)
Table S1 Putative LanL proteins found in the databases
and the organisms of origin.
Found at: doi:10.1371/journal.pbio.1000339.s010 (0.28 MB TIF)
Table S2 Oligonucleotide primers used in this study.
a Restriction sites are underlined.
b Mutant nucleotides are
highlighted in bold.
Found at: doi:10.1371/journal.pbio.1000339.s011 (0.76 MB TIF)
Table S3 List of bacteria containing LanB, LanM, and
LanL genes. The genes that were used to construct Figure 6 and
their accession numbers are shown. The list is not meant to be
comprehensive (for instance some of the known lantibiotic
producers were not included) but meant to illustrate the general
distribution of these genes.
Found at: doi:10.1371/journal.pbio.1000339.s012 (0.02 MB PDF)
Table S4 Species and strains with genes for more than
one pathway to lanthionine-containing peptides. Figure 6
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PLoS Biology | www.plosbiology.org 9 March 2010 | Volume 8 | Issue 3 | e1000339in the main text shows species with genes for more than one
pathway to lanthionine-containing peptides. In some cases, these
genes are found in one strain; in other cases, the genes are found in
different strains. For accession numbers, see Table S3.
Found at: doi:10.1371/journal.pbio.1000339.s013 (0.01 MB PDF)
Text S1 Molecular biology procedures, antimicrobial
assays, and enzyme expression and purification proto-
cols. Description of procedures used to construct the plasmids
VenL/pET28, VenL-DC/pET28, VenL-DLC/pET28, VenL-
DKC/pET28, and MBP-VenA/pET28. Also provided are the
expression and purification protocols for these proteins and the
methods used for site-directed mutagenesis of venA. Construction
of the DvenL, DvenA, and ermEp*::venL derivatives of S. venezuelae are
also described as well as antimicrobial assays with venezuelin and
its analogs.
Found at: doi:10.1371/journal.pbio.1000339.s014 (0.09 MB PDF)
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